What is Molecular Assemblies?
Molecular Assemblies is a San Diego-based life sciences enterprise specializing in enzymatic DNA synthesis. By mimicking natural biological processes, the company produces long, sequence-specific DNA that is both reliable and cost-effective. This technology serves as a foundational element for diverse sectors, including precision medicine, industrial synthetic biology, and the emerging field of DNA-based data storage. The company's patented approach addresses the limitations of traditional chemical synthesis, offering a more sustainable and scalable alternative for researchers and commercial entities alike. As a key innovator in the biotechnology space, Molecular Assemblies is bridging the gap between theoretical genetic research and practical, market-ready applications.
How much funding has Molecular Assemblies raised?
Molecular Assemblies has raised a total of $57.1M across 6 funding rounds:
Private Equity
$4.5M
Angel/Seed
$2.3M
Debt
$150K
Debt
$325K
Series A
$24M
Series B
$25.8M
Private Equity (2016): $4.5M, investors not publicly disclosed
Angel/Seed (2016): $2.3M led by Genomics Investment Syndicate, 11.2 Capital, Cavendish Impact Capital Fund, Agilent Technologies, Newport Holdings, LP, and Alexandria Venture Investments
Debt (2020): $150K supported by PPP
Debt (2021): $325K featuring PPP
Series A (2021): $24M backed by LYFE Capital, Agile Technologies, Argonautic Ventures, Codexis, iSelect Fund Management, and Alexandria Venture Investments
Series B (2022): $25.8M with participation from LYFE Capital, iSelect Fund Management, Agilent Technologies, Argonautic Ventures, Casdin Capital, and Codexis
Key Investors in Molecular Assemblies
LYFE Capital
LYFE Capital is a premier healthcare investment platform that connects healthcare champions with global markets, supply chains, and strategic partners, focusing on scaling high-potential businesses in the healthcare sector.
iSelect Fund Management
iSelect Fund is a venture capital firm focused on the intersection of food, health, and AgTech, supporting innovative companies that enhance food quality and improve health outcomes.
Agilent Technologies
Agilent Technologies is a global leader in life sciences, diagnostics, and applied markets, providing advanced instruments and services to support research and pharmaceutical development worldwide.
What's next for Molecular Assemblies?
With the infusion of recent capital, Molecular Assemblies is poised to transition from its current development phase toward broader commercialization. The strategic focus will likely center on scaling its enzymatic manufacturing capabilities to meet the growing demand for high-fidelity DNA in therapeutic development and bio-based electronics. Furthermore, the company is expected to leverage its partnerships with industry leaders to refine its ECO Synthesis platform, ensuring that its technology remains at the forefront of the synthetic biology market. As the firm continues to optimize its production workflows, it remains a primary candidate for further integration into the global supply chains of pharmaceutical and diagnostic giants, potentially setting new standards for efficiency and sustainability in the life sciences sector.
See full Molecular Assemblies company page
